![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
GE Healthcare |
---|---|
Information provided by: | GE Healthcare |
ClinicalTrials.gov Identifier: | NCT00783302 |
To assess prognostic value of CCTA examination in subjects who undergo CCTA as part of their medical care when compared to a standard of truth, i.e. subject outcomes during each follow-up period.
Condition |
---|
Coronary Artery Disease (CAD) |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | A Prospective, Multi-Center Registry Study for Clinical Outcome in Subjects Undergoing Coronary Computed Tomography Angiography (CCTA) Examination (VISIPAQUE Registry Study) |
Estimated Enrollment: | 1000 |
Study Start Date: | September 2008 |
Estimated Study Completion Date: | December 2010 |
Estimated Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Patient suspected of having coronary artery disease or CAD.
Inclusion Criteria:
Contact: Veronica Reichl | 609-514-6849 | veronica.reichl@ge.com |
United States, New Jersey | |
GE Healthcare | Recruiting |
Princeton, New Jersey, United States, 08540 |
Principal Investigator: | Rubin Sheng, M.D. | GE Healthcare |
Responsible Party: | GE Healthcare ( Rubin Sheng, M.D. ) |
Study ID Numbers: | GE-012-096 |
Study First Received: | October 30, 2008 |
Last Updated: | October 30, 2008 |
ClinicalTrials.gov Identifier: | NCT00783302 |
Health Authority: | United States: Institutional Review Board; Canada: Health Canada |
CAD Visipaque CCTA |
Arterial Occlusive Diseases Coronary Disease Heart Diseases Myocardial Ischemia |
Vascular Diseases Arteriosclerosis Ischemia Coronary Artery Disease |
Cardiovascular Diseases |